Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. Cartilage Repair interventions aim to regenerate, restore, or replace articular cartilage to reduce joint pain and to prevent the development of arthritis. GlobalData uses proprietary data and analytics to provide a comprehensive report on the cartilage repair market in Australia. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the cartilage repair market in Australia was Smith & Nephew followed by Arthrex, Zimmer Biomet, DePuy Synthes, Stryker and ConMed.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Cartilage Repair interventions can occur early in the spectrum of joint damage and offer an opportunity for patients to delay or altogether avoid needing total joint replacement surgery. Articular cartilage damage generally occurs via two main routes: sports-related and traumatic injury, as well as through inflammatory arthropathies. There are several approaches employed to treat chondral lesions (cartilage damage) in the joints. Cartilage Repair includes Platelet-Rich Plasma (PRP) Injection, Extracellular Matrix Implants, Intact Tissue Implants, and Marrow Stimulation (Microfracture). Platelet-Rich Plasma (PRP) Injection Devices are able to draw a patient's own blood and process it into Platelet-Rich Plasma through centrifugation and collection of the platelet-rich component. Extracellular Matrix Implants are decellularized implants that match or mimic the 3D structure of cartilage. Intact Tissue Implants are of two types: Osteochondral Allografts and Meniscal Allografts. Marrow Stimulation (Microfracture) interventions involve creating small holes in subchondral bone to produce a bleeding effect.
The cartilage repair market in Australia can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size cartilage repair in Australia, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
